Vitamin D deficiency in melanoma patients is associated with worse overall survival: a retrospective cohort study.
Journal
Melanoma research
ISSN: 1473-5636
Titre abrégé: Melanoma Res
Pays: England
ID NLM: 9109623
Informations de publication
Date de publication:
01 10 2022
01 10 2022
Historique:
pubmed:
19
8
2022
medline:
9
9
2022
entrez:
18
8
2022
Statut:
ppublish
Résumé
Recent interest has emerged in the protective role of vitamin D in melanoma survival and is the subject of multiple studies with heterogeneous results. Here, we present a retrospective cohort study of 264 patients with invasive melanoma from a tertiary university hospital. The aim of the study was to analyze the relationship between vitamin D levels and prognosis of melanoma patients. We found that lower vitamin D levels are independently associated with worse overall survival in melanoma patients in concordance with previous studies on other populations. Vitamin D deficiency could play a survival role in melanoma patients,. Future prospective studies are needed to investigate the effect of vitamin D supplementation on melanoma outcomes.
Identifiants
pubmed: 35979670
doi: 10.1097/CMR.0000000000000842
pii: 00008390-202210000-00012
doi:
Substances chimiques
Vitamin D
1406-16-2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
384-387Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Références
Newton-Bishop JA, Davies JR, Latheef F, Randerson-Moor J, Chan M, Gascoyne J, et al. 25-Hydroxyvitamin D 2/D 3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort. Int J Cancer. 2015; 136:2890–2899.
Paolino G, Moliterni E, Corsetti P, Didona D, Bottoni U, Calvieri S, Mattozzi C. Vitamin D and melanoma: state of the art and possible therapeutic uses. G Ital Dermatol Venereol. 2019; 154:64–71.
Vasilovici AF, Grigore LE, Ungureanu L, Fechete O, Candrea E, Trifa AP, et al. Vitamin D receptor polymorphisms and melanoma. Oncol Lett. 2019; 17:4162–4169.
Mahamat-Saleh Y, Aune D, Schlesinger S. 25-Hydroxyvitamin D status, vitamin D intake, and skin cancer risk: a systematic review and dose-response meta-analysis of prospective studies. Sci Rep. 2020; 10:13151.
Ogbah Z, Visa L, Badenas C, Ríos J, Puig-Butille JA, Bonifaci N, et al. Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona. BMC Med Genet. 2013; 14:26.
Tsai T-Y, Kuo C-Y, Huang Y-C. The association between serum vitamin D level and risk and prognosis of melanoma: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2020; 34:1722–1729.
Timerman D, McEnery-Stonelake M, Joyce CJ, Nambudiri VE, Hodi FS, Claus EB, et al. Vitamin D deficiency is associated with a worse prognosis in metastatic melanoma. Oncotarget. 2017; 8:6873–6882.
Saiag P, Aegerter P, Vitoux D, Lebbé C, Wolkenstein P, Dupin N, et al. Prognostic value of 25-hydroxyvitamin D3 levels at diagnosis and during follow-up in melanoma patients. J Natl Cancer Inst. 2015; 107:djv264.
van der Pols JC, Russell A, Bauer U, Neale RE, Kimlin MG, Green AC. Vitamin D status and skin cancer risk independent of time outdoors: 11-year prospective study in an Australian community. J Invest Dermatol. 2013; 133:637–641.
Gandini S, De Vries E, Tosti G, Botteri E, Spadola G, Maisonneuve P, et al. Sunny holidays before and after melanoma diagnosis are respectively associated with lower Breslow thickness and lower relapse rates in Italy. PLoS One. 2013; 8:e78820.
Asgari MM, Maruti SS, Kushi LH, White E. A cohort study of vitamin D intake and melanoma risk. J Invest Dermatol. 2009; 129:1675–1680.
Tang JY, Fu T, Leblanc E, Manson JE, Feldman D, Linos E, et al. Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women’s health initiative randomized controlled trial. J Clin Oncol. 2011; 29:3078–3084.
Johansson H, Spadola G, Tosti G, Mandalà M, Minisini AM, Queirolo P, et al. Vitamin D supplementation and disease-free survival in stage ii melanoma: a randomized placebo controlled trial. Nutrients. 2021; 13:1931.
Navarro-Triviño FJ, Arias-Santiago S, Gilaberte-Calzada Y. Vitamina D y la piel. Una revisión para dermatólogos. Actas Dermosifiliogr. Elsevier Doyma. 2019; 110:262–272.
Garland CF, French CB, Baggerly LL, Heaney RP. Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res. 2011; 31:607–611.
Lim A, Shayan R, Varigos G. High serum vitamin D level correlates with better prognostic indicators in primary melanoma: a pilot study. Australas J Dermatol. 2018; 59:182–187.